Patent EP0305551A2 successfully refreshed from Google Patents.
EP0305551A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Pharmaceutical compositions for topical application
Assignee: Exovir Inc
•
Filing: 1982-10-11
•
Granted: —
•
Expires: 2002-10-11
Abstract
Abstract Described are pharmaceutical compositions consisting of a physiologically acceptable support containing or coated with an effective amount of human interferon and an antiviral surface active agent for topical application.
Inventors
- 👤 Samuel S. Asculai
- 👤 Fred Rapp
- 👤 Daniel G. M. D. Miller
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-05 04:09
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/19; A61K38/21
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
42 words
A pharmaceutical composition consisting of a physiologically acceptable support containing or coated with 10² to 10⁸ I.U. per dosage unit of a human interferon, an effective amount of an antiviral nonionic surface active agent, and a physiologically acceptable carrier for topical application.
Claim 2
Dependent Claim
42 words
A pharmaceutical composition consisting of a physiologically acceptable support containing or coated with 10² to 10⁸ I.U. per dosage unit of a human interferon, an effective amount of an antiviral nonionic surface active agent, and a physiologically acceptable carrier for topical application.
Claim 3
Dependent Claim
24 words
The composition of Claim 1 wherein the amount of antiviral surface active agent is 0.1 to 20 %, preferably 1 % to 5 %.
Claim 4
Dependent Claim
19 words
The composition of Claim 1 wherein the nonionic surface active agent has at least one ether or amide linkage.
Claim 5
Dependent Claim
23 words
The composition of Claim 3 wherein the nonionic surface active agent is nonylphenoxy-polyethoxy ethanol, p-diisobutylphenoxy-polyethoxy ethanol, polyoxyethylene (10) oleyl ether, or Onyx-ol® 345.
Claim 6
Dependent Claim
12 words
The composition of Claim 4 wherein the human interferon is leukocyte interferon.
Claim 7
Dependent Claim
16 words
The composition of Claim 5 wherein the amount of human interferon is 10⁴ to 10⁶ I.U.
Claim 8
Dependent Claim
18 words
The composition of Claim 1 wherein said carrier is a pharmaceutically acceptable carrier and/or a cosmetically acceptable carrier.
Claim 9
Dependent Claim
19 words
The composition of Claim 1 wherein the carrier includes water, ethanol, polyethylene glycol, mineral oil, petrolatum, or propylene glycol.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.